Science

Why Does Weed Give You Cotton Mouth? The Salivary Gland Connection

By RethinkTHC Research Team|15 min read|March 5, 2026

Science

70%

A 2006 study found CB1 and CB2 receptors directly on submandibular salivary gland cells, proving THC suppresses the source of 70% of your resting saliva.

Experimental Biology and Medicine, 2017

Experimental Biology and Medicine, 2017

Infographic showing cannabinoid receptors on salivary glands suppress 70 percent of resting saliva productionView as image

You know the feeling. Within minutes of using cannabis, your mouth goes from normal to desert. Your tongue sticks to the roof of your mouth. Swallowing feels like work. Talking requires deliberate effort to unstick surfaces that are supposed to glide effortlessly. You reach for water, and it helps for about thirty seconds before the dryness returns.

Cotton mouth is so universally associated with cannabis that it has become a cultural punchline. But the science behind it is more interesting than most people realize, because it reveals that cannabis does not just affect your brain. The endocannabinoid system extends throughout your body, including to places you would never expect, like the cells that produce your saliva.

Key Takeaways

  • Cotton mouth (xerostomia) isn't caused by smoke drying your mouth out — it happens with edibles, tinctures, and every other method too, because THC is directly shutting down saliva production
  • A 2006 study in Experimental Biology and Medicine found CB1 and CB2 receptors right on the submandibular salivary gland cells, proving THC suppresses saliva at the source
  • Those submandibular glands make about 70% of your resting saliva, and THC blocks the nerve signals that tell them to keep producing it
  • Your body's own endocannabinoid, anandamide, also dials down saliva when it binds to these same receptors — so the endocannabinoid system naturally plays a role in how much spit you make
  • Chronic dry mouth from heavy cannabis use raises your risk of cavities, gum disease, and oral infections, because saliva is one of your mouth's main defenses
  • CBD barely touches CB1 receptors and doesn't cause much dry mouth on its own, which is why THC-dominant products make your mouth drier than balanced or CBD-dominant ones

The Misconception: Smoke Dries You Out

Science

Cotton Mouth: THC Shuts Down Saliva at the Source

1THC reaches submandibular glands

These glands produce ~70% of your resting saliva

2CB1 and CB2 receptors activated

Found directly on salivary gland cells (Prestifilippo, 2006)

3Parasympathetic signaling blocked

Nerve signals that trigger saliva production are suppressed

4Saliva production drops sharply

Mouth goes from normal to desert within minutes

Myths vs. Reality
Myth: Smoke dries your mouth out
Reality: Edibles, patches, and capsules cause it too — it's systemic, not local
Myth: Drinking water fixes it
Reality: Temporarily helps, but dryness returns because production is still suppressed
Myth: All cannabinoids cause it equally
Reality: CBD barely touches CB1 receptors and causes much less dry mouth

Long-term concern: Chronic dry mouth from heavy cannabis use raises risk of cavities, gum disease, and oral infections — saliva is one of your mouth's main defenses against bacteria.

Prestifilippo et al., Exp Biol Med, 2006Cotton Mouth: THC and Salivary Glands

The most common casual explanation for cotton mouth is that smoke dehydrates the mouth. This makes intuitive sense. Hot, dry smoke passing over your oral tissues would logically dry them out, right?

But this explanation falls apart almost immediately. Cotton mouth occurs with edibles. It occurs with tinctures dropped under the tongue. It occurs with THC capsules swallowed whole. People using transdermal THC patches, which involve no oral exposure whatsoever, report dry mouth. The method of consumption does not matter. If THC gets into your bloodstream, cotton mouth follows.

Smoking anything, cannabis or otherwise, does mildly dehydrate oral tissues through direct thermal and chemical effects. Tobacco smokers experience some oral dryness too. But the cotton mouth from cannabis is qualitatively different: more severe, more immediate, and present regardless of how the THC enters your body. Something else is going on.

The Real Mechanism: Cannabinoid Receptors on Salivary Glands

The breakthrough came from a 2006 study by Prestifilippo and colleagues published in Experimental Biology and Medicine. The researchers were investigating the presence of cannabinoid receptors in tissues outside the brain when they discovered something unexpected: both CB1 and CB2 receptors are expressed directly on the cells of the submandibular salivary glands.

This was a significant finding because the submandibular glands are the workhorse glands of your salivary system. You have three pairs of major salivary glands: the parotid glands (in front of your ears), the sublingual glands (under your tongue), and the submandibular glands (under your jaw). The submandibular glands produce approximately 70% of your resting saliva, the continuous background flow that keeps your mouth moist when you are not actively eating.

When THC binds to the CB1 and CB2 receptors on these gland cells, it inhibits the signals that normally trigger saliva secretion. Specifically, it interferes with the parasympathetic nervous system input that drives resting salivary flow. The parasympathetic nervous system uses the neurotransmitter acetylcholine to stimulate salivary glands, and cannabinoid receptor activation on these cells reduces their responsiveness to that acetylcholine signal.

The result is not that saliva production stops completely. It is that it drops significantly, particularly the thin, watery, serous component that makes up most of resting saliva. The small amount of saliva that continues to be produced tends to be thicker and more mucous-heavy, which contributes to the sticky, unpleasant texture that characterizes cotton mouth.

Your Body Already Uses This System

Here is the part that surprised researchers: the endocannabinoid system is naturally involved in regulating saliva production. Your body produces its own cannabinoids, anandamide and 2-AG, and these endocannabinoids bind to the same CB1 and CB2 receptors on salivary gland cells that THC targets.

Prestifilippo's team showed that injecting anandamide directly reduced salivary output in a dose-dependent manner, just like THC. This means your body has a built-in mechanism for dialing saliva production up and down, and the endocannabinoid system is part of that regulatory process.

This makes biological sense. Saliva production needs to be variable. You need more when you are eating (to begin digestion and lubricate food for swallowing) and less when you are not. The parasympathetic system stimulates production; the endocannabinoid system appears to be one of the mechanisms that moderates it. THC simply overwhelms this modulation, pushing saliva suppression far beyond the normal range.

The Autonomic Nervous System Connection

Beyond the direct glandular effect, THC also affects saliva production through its impact on the autonomic nervous system.

Salivary flow is controlled by both branches of the autonomic nervous system, but in opposite ways. Parasympathetic activation (rest and digest) stimulates copious, watery saliva production. This is why your mouth waters when you smell food; the parasympathetic system is preparing your mouth for eating. Sympathetic activation (fight or flight) produces a small amount of thick, protein-rich saliva, which is why your mouth goes dry when you are nervous or scared.

As discussed in other contexts, THC acutely shifts autonomic balance toward sympathetic dominance in many systems. In the salivary glands, this means reduced parasympathetic drive (less watery saliva) and relatively increased sympathetic influence (thicker, scanty secretion). This autonomic shift compounds the direct receptor-mediated suppression at the gland, producing a more profound dry mouth than either mechanism alone would create.

Why Some People Get It Worse Than Others

If you have used cannabis with a group, you have probably noticed that cotton mouth severity varies considerably between people. One person is desperately gulping water while another barely notices any dryness. Several factors explain this variation.

Baseline salivary flow rate differs between individuals by as much as threefold. People who naturally produce more saliva have a bigger buffer before the THC-mediated reduction becomes noticeable. Genetics, hydration status, medications, and even time of day (salivary flow is lowest during sleep and highest during meals) all influence baseline flow.

Other medications matter enormously. Hundreds of prescription and over-the-counter drugs cause dry mouth as a side effect, including antidepressants, antihistamines, blood pressure medications, and decongestants. If you are already taking one of these medications and then add cannabis, the combined suppression of salivary flow can be severe.

The dose and potency of cannabis directly correlate with the degree of dry mouth, as the receptor-mediated suppression is dose-dependent. Higher THC concentrations mean more CB1 activation on salivary gland cells and more pronounced flow reduction.

Interestingly, CBD does not appear to produce significant dry mouth on its own, though some users of high-CBD products do report mild dryness. This is consistent with the mechanism being primarily CB1-mediated, as CBD has very low affinity for CB1 receptors. Products with balanced THC-to-CBD ratios may produce less cotton mouth than THC-dominant products, though this has not been formally studied in controlled trials.

The Oral Health Consequences

For occasional cannabis users, cotton mouth is an annoying but harmless side effect that resolves as THC is metabolized. But for daily or heavy users, chronic reduction in salivary flow has real consequences for oral health.

Saliva is not just water. It is a complex fluid containing enzymes, antibodies, minerals, and buffering agents that play critical roles in protecting your mouth. Specifically, saliva continuously remineralizes tooth enamel with calcium and phosphate. It contains antimicrobial proteins (lysozyme, lactoferrin, secretory IgA) that control bacterial populations. It buffers acids produced by oral bacteria after they metabolize sugars. And it physically washes away food debris and bacteria.

When salivary flow is chronically reduced, all of these protective functions are compromised. The result is an increase in dental caries (cavities), periodontal (gum) disease, oral candidiasis (yeast infections), and halitosis (bad breath). Dental professionals have increasingly recognized cannabis-related xerostomia as a clinical concern, particularly as cannabis use has become more widespread.

A 2017 review by Cho and colleagues in the Australian Dental Journal examined the oral health effects of cannabis use and found consistent associations between heavy cannabis use and increased rates of dental caries, particularly on root surfaces and at the gumline, areas that are most vulnerable when salivary protection is reduced.

What Actually Helps (and What Does Not)

The most common response to cotton mouth is drinking water, and while hydration is always a good idea, water provides only temporary relief because the problem is not dehydration. The problem is that your salivary glands are being suppressed. Drinking water wets your mouth momentarily, but it does not restart salivary flow.

More effective strategies target the glands themselves. Sour candies or foods stimulate salivary flow reflexively through the gustatory-salivary reflex, the same mechanism that makes your mouth water when you eat something sour. Citric acid in particular is a potent salivary stimulant. Sugar-free sour candies provide the stimulatory effect without adding sugar that would compound the dental risk.

Chewing gum is another effective salivary stimulant. The mechanical act of chewing activates salivary flow through both the masticatory-salivary reflex and the gustatory reflex (if the gum is flavored). Sugar-free gum with xylitol is ideal because xylitol actively inhibits the oral bacteria that cause cavities.

Biotene and other saliva-substitute products are designed for chronic dry mouth and can be helpful for heavy cannabis users. They contain carboxymethylcellulose or similar agents that mimic the lubricating properties of natural saliva. They do not stimulate natural production but they do protect the oral tissues.

Alcohol-based mouthwashes should be avoided during cannabis use because alcohol is a desiccant that further dries oral tissues. If you want to use mouthwash, choose an alcohol-free formulation.

The Cannabis Munchies Connection

There is an ironic physiological connection between cotton mouth and the munchies, cannabis's other famous side effect. Both involve the endocannabinoid system's role in eating behavior.

Under normal conditions, the anticipation and consumption of food triggers a parasympathetic response that increases salivary flow, preparing your mouth for eating. THC simultaneously stimulates appetite (through CB1 receptors in the hypothalamus and limbic system) while suppressing the salivary response that normally accompanies eating. You want to eat everything in sight, but your mouth is too dry to comfortably chew and swallow.

This is a pharmacological contradiction that does not occur in nature. Your body's own endocannabinoids contribute to both appetite regulation and saliva modulation, but in a coordinated way. THC disrupts that coordination by activating both systems simultaneously at supraphysiological levels, producing the awkward combination of intense hunger and a mouth that feels like sandpaper.

The Bottom Line on Cotton Mouth

Cotton mouth is not a mystery and it is not caused by smoke. It is a direct pharmacological effect of THC binding to cannabinoid receptors on the cells that produce your saliva. The same endocannabinoid system that is present in your brain, your gut, your immune system, and dozens of other tissues is also present in your salivary glands, and THC activates it indiscriminately.

For occasional users, it is a minor inconvenience managed with water and sour candy. For daily users, it warrants attention to oral hygiene and dental health, because the protective functions of saliva are not optional. Your teeth and gums depend on a constant bath of saliva that cannabis chronically reduces, and the consequences accumulate quietly over months and years.

The Bottom Line

Pharmacology of cannabis-induced xerostomia covering salivary gland CB receptors, autonomic mechanisms, and oral health consequences. Core mechanism: Prestifilippo 2006 Experimental Biology and Medicine — CB1 and CB2 receptors directly on submandibular salivary gland cells; THC binding inhibits parasympathetic acetylcholine-mediated saliva secretion; submandibular glands produce ~70% resting saliva. Not smoke: edibles, tinctures, capsules, transdermal patches all cause cotton mouth; confirms systemic pharmacological effect not thermal/chemical irritation. Endocannabinoid role: anandamide also reduces salivary output dose-dependently via same receptors; natural modulation of saliva production. Autonomic: THC shifts toward sympathetic dominance; parasympathetic = copious watery saliva, sympathetic = thick scanty saliva; compounds direct glandular suppression. Residual saliva thicker/more mucous = sticky texture. Individual variation: 3-fold baseline flow rate differences, medication interactions (antidepressants, antihistamines compound dryness), dose-dependent. CBD: low CB1 affinity = does not produce significant cotton mouth alone. Oral health: Cho 2017 Australian Dental Journal — chronic cannabis use associated with increased dental caries (root surfaces, gumline), periodontal disease, oral candidiasis; saliva functions (remineralization, antimicrobial, pH buffering, debris clearance) all compromised. Management: sour candy (gustatory-salivary reflex), sugar-free xylitol gum, Biotene saliva substitutes, avoid alcohol mouthwash. Munchies connection: THC stimulates appetite while suppressing salivary response = pharmacological contradiction not found in natural endocannabinoid signaling.

Frequently Asked Questions

Sources & References

  1. 1RTHC-07874·Vikingsson, Svante et al. (2025). Legal CBD Products With Trace THC Can Cause Positive Drug Tests in Oral Fluid.” Journal of analytical toxicology.Study breakdown →PubMed →
  2. 2RTHC-07936·Weiss, Marisa et al. (2025). A CBD/THC Combination Did Not Significantly Improve Chemotherapy-Induced Nerve Damage in a Rigorous Trial.” Frontiers in oncology.Study breakdown →PubMed →
  3. 3RTHC-07860·Velzeboer, Rob et al. (2025). Cannabis Doesn't Consistently Change Sleep Patterns — But Withdrawal Clearly Disrupts Sleep.” Sleep medicine reviews.Study breakdown →PubMed →
  4. 4RTHC-08302·Guo, Xiucheng et al. (2026). New Structural Insights Into How Cannabinoid Receptors Work.” Biochemical pharmacology.Study breakdown →PubMed →
  5. 5RTHC-07953·Williams, Mollie V et al. (2025). How Emergency Departments Handle Cannabis-Related Emergencies.” Emergency medicine practice.Study breakdown →PubMed →
  6. 6RTHC-07868·Vigano, MariaLuisa et al. (2025). Cannabis May Help Cancer Patients Tolerate Immunotherapy — But Could Reduce Its Effectiveness.” Frontiers in immunology.Study breakdown →PubMed →
  7. 7RTHC-07897·Wagner, Yvonne et al. (2025). A 1:1 THC:CBD Cannabis Extract Significantly Reduced Chronic Pain in German Patients.” Advances in therapy.Study breakdown →PubMed →
  8. 8RTHC-07849·van den Berg, Pieter F et al. (2025). Two Patients With Advanced Liver Cancer Achieved Complete Tumor Regression Using Cannabis Oil.” Journal of cannabis research.Study breakdown →PubMed →

Research Behind This Article

Showing the 8 most relevant studies from our research database.

Strong Evidenceclinical-trial

The Acute and Chronic Pharmacokinetic Oral Fluid Profile of Oral Cannabidiol (CBD) With and Without Low Doses of Delta-9-Tetrahydrocannabinol (Δ9-THC) in Healthy Human Volunteers.

Vikingsson, Svante · 2025

After taking 100 mg CBD with just 0.5 mg THC (well within legal hemp limits), 1 in 10 participants tested positive for THC in oral fluid.

Strong Evidenceclinical-trial

Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial.

Weiss, Marisa · 2025

The active group receiving CBD (125.3–135.9 mg) combined with THC (6.0–10.8 mg) in gelcaps did not show statistically significant improvement on the primary outcome (QLQ-CIPN20 sensory subscale) compared to placebo over 12 weeks, though some secondary endpoints suggested potential trends..

Moderate EvidenceSystematic Review

Cannabis and sleep architecture: A systematic review and meta-analysis.

Velzeboer, Rob · 2025

Across 18 studies (9 in meta-analysis), cannabis administration did not consistently alter sleep duration, latency, wake time, efficiency, or sleep staging.

Moderate EvidenceReview

Structural and dynamic mechanisms of cannabinoid receptors.

Guo, Xiucheng · 2026

Structural studies of CB1 and CB2 receptors have deepened understanding of receptor activation mechanisms, allosteric modulation sites, transducer coupling selectivity, and dynamic conformational changes — providing a foundation for designing therapeutics with improved subtype selectivity and reduced off-target effects..

Moderate EvidenceNarrative Review

Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy.

Vigano, MariaLuisa · 2025

Cannabis use in cancer patients receiving immune checkpoint inhibitors (ICIs) reduces immune-related adverse events and improves tolerability, but several studies noted potential negative effects on clinical outcomes including overall survival and progression-free survival, possibly due to CB2-mediated immunosuppression..

Moderate EvidenceReview

Diagnosis and management of cannabis-related emergencies.

Williams, Mollie V · 2025

Emergency departments are seeing increasing cannabis-related visits; management differs significantly between natural cannabis and synthetic cannabinoid presentations, with synthetic products carrying higher risk of severe outcomes..

Moderate Evidenceclinical-observation

How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical® Hybrid Cannabis Extract.

Wagner, Yvonne · 2025

Mean pain intensity (NRS) decreased from 5.46 to 3.37 in the full population (n=64) and from 5.92 to 2.37 in cannabis-naïve patients (n=35).

Preliminary Evidenceclinical-observation

Durable complete response of advanced hepatocellular carcinoma using cannabis oil: a report of two cases.

van den Berg, Pieter F · 2025

Both patients (ages 82 and 77) with advanced hepatocellular carcinoma and high tumor burden achieved complete and durable tumor regression after using sublingual cannabis oil containing THC and CBD, with no other anti-cancer treatment..